CTY volume 21 issue 4 Cover and Front matter
Jeffery Meadows(Deutsches Herzzentrum der Charité), Wilfried Bellinghausen(Cambridge University Press), Farhad Bakhtiary(Cambridge University Press), Davide Marini(University of Toronto), John W. Stirling(Versus Arthritis), John J. Lamberti(Versus Arthritis), Éric Rosenthal(St Bartholomew's Hospital), Thomas Krasemann(Versus Arthritis), Mark Robertson(Versus Arthritis), Simon Jackson(Cambridge University Press), Claudio Defilippi(Cambridge University Press), Haley Burton(Cambridge University Press), Rachel Webb(Versus Arthritis), Irene Zeng(Versus Arthritis), Raymond R. Balise(Cambridge University Press), Aphrodite Tzifa(Mitera Hospital), Adrian Trenholme(Versus Arthritis), Clare O'donnell(Cambridge University Press), B. Branger(Versus Arthritis), Andrew Warren(Dalhousie University), Shakeel Qureshi(Versus Arthritis), Kathy J. Jenkins(Boston Children's Hospital), Thomas L. Gentles(Versus Arthritis), Nicolas Joram(Cambridge University Press), Stephen P. Seslar(Cambridge University Press), Jean‐Christophe Rozé(Centre Hospitalier Universitaire de Nantes), Chitra Ravishankar(Children's Hospital of Philadelphia), Rajesh Punn(Lucile Packard Children's Hospital), Ross Nicholson(Versus Arthritis), Bradley S. Marino, C. Manteau(Cambridge University Press), Gabriella Agnoletti(Versus Arthritis), Pierre-Emmanuel Se ́gue ́la(Versus Arthritis), Ayya Syama(Versus Arthritis), Ben Lotfi(Versus Arthritis), Gerardus Mime(Versus Arthritis), David Liu(Bristol-Myers Squibb (Germany)), Nigel Wilson(Cambridge University Press), Elizabeth Wilson(Versus Arthritis), Jeffrey Anderson(Cambridge University Press), jrv a(Versus Arthritis), K. E. Fleming(Versus Arthritis), Jean‐Luc Orsonneau(Cambridge University Press), Narayanswami Sreeram(Versus Arthritis), Ve ́ronique Gournay(Versus Arthritis), Diana Lennon(Cambridge University Press), B. Romefort(Versus Arthritis), Camille Hancock Friesen(Cambridge University Press), Ranjith Karthekeyan(Cambridge University Press), Sharon Y. Irving(Children's Hospital of Philadelphia)
Cited by 0
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
|Journal of Clinical Oncology|2013|596
Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association
|Circulation|2019|405
Brain in Congenital Heart Disease Across the Lifespan
|Circulation|2016|363
D-Transposition of the Great Arteries
|Journal of the American College of Cardiology|2014|287